Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 169–176 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Agenus Inc. AgenT-797 Refractory (2L+) gastric cancer, refractory gastroesophageal cancer (GEC) Phase 2 Data Released Intravenous Oncology
Agenus Inc. Neoadjuvant BOT/BAL - (NEOASIS) Early-Stage Solid Tumors Phase 2 Data Released Intravesical Oncology
Agenus Inc. Neoadjuvant botensilimab plus balstilimab - (NEST-1) Colorectal cancer Phase 2 Data Released Intravenous Oncology
Agenus Inc. Balstilimab Advanced/metastatic non-melanoma skin cancers (Agenonmela) Phase 2 Ongoing Intravenous Oncology
Agenus Inc. Botensilimab - (ACTIVATE) Advanced MSS Colorectal Cancer and Advanced Melanoma BLA Filing Data Released Intravenous Oncology
Agenus Inc. Balstilimab Cervical cancer BLA Filing Withdrawn Intravenous Oncology
Agenus Inc. AGEN1423 with Balstilimab Pancreatic Cancer Phase 2 Ongoing Intravenous Oncology
Agenus Inc. AGEN1423 Advanced pancreatic cancer Phase 2 Ongoing Intravenous Oncology